» Articles » PMID: 28926199

Automated Detection of Diabetic Retinopathy Lesions on Ultrawidefield Pseudocolour Images

Overview
Journal Acta Ophthalmol
Specialty Ophthalmology
Date 2017 Sep 20
PMID 28926199
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We examined the sensitivity and specificity of an automated algorithm for detecting referral-warranted diabetic retinopathy (DR) on Optos ultrawidefield (UWF) pseudocolour images.

Methods: Patients with diabetes were recruited for UWF imaging. A total of 383 subjects (754 eyes) were enrolled. Nonproliferative DR graded to be moderate or higher on the 5-level International Clinical Diabetic Retinopathy (ICDR) severity scale was considered as grounds for referral. The software automatically detected DR lesions using the previously trained classifiers and classified each image in the test set as referral-warranted or not warranted. Sensitivity, specificity and the area under the receiver operating curve (AUROC) of the algorithm were computed.

Results: The automated algorithm achieved a 91.7%/90.3% sensitivity (95% CI 90.1-93.9/80.4-89.4) with a 50.0%/53.6% specificity (95% CI 31.7-72.8/36.5-71.4) for detecting referral-warranted retinopathy at the patient/eye levels, respectively; the AUROC was 0.873/0.851 (95% CI 0.819-0.922/0.804-0.894).

Conclusion: Diabetic retinopathy (DR) lesions were detected from Optos pseudocolour UWF images using an automated algorithm. Images were classified as referral-warranted DR with a high degree of sensitivity and moderate specificity. Automated analysis of UWF images could be of value in DR screening programmes and could allow for more complete and accurate disease staging.

Citing Articles

Utilizing fundus images captured by two ultra-wide field imaging systems to measure diagnostic indicators and assess the grade of diabetic retinopathy.

Sun Y, Chen X, Song Z, Liu T, Tao Y, Lai T BMC Ophthalmol. 2025; 25(1):72.

PMID: 39930419 PMC: 11812173. DOI: 10.1186/s12886-024-03835-6.


Artificial intelligence-based prediction of diabetic retinopathy evolution (EviRed): protocol for a prospective cohort.

Tadayoni R, Massin P, Bonnin S, Magazzeni S, Lay B, Le Guilcher A BMJ Open. 2024; 14(4):e084574.

PMID: 38626974 PMC: 11029320. DOI: 10.1136/bmjopen-2024-084574.


Assessing Diabetic Retinopathy Staging With AI: A Comparative Analysis Between Pseudocolor and LED Imaging.

Cicinelli M, Gravina S, Rutigliani C, Checchin L, La Franca L, Lattanzio R Transl Vis Sci Technol. 2024; 13(3):11.

PMID: 38488432 PMC: 10946690. DOI: 10.1167/tvst.13.3.11.


The use of artificial intelligence to assess diabetic eye disease among the Greenlandic population.

Larsen T, Pettersen M, Nygaard Jensen H, Pedersen M, Lund-Andersen H, Jorgensen M Int J Circumpolar Health. 2024; 83(1):2314802.

PMID: 38359160 PMC: 10877649. DOI: 10.1080/22423982.2024.2314802.


Imaging Modalities for Assessing the Vascular Component of Diabetic Retinal Disease: Review and Consensus for an Updated Staging System.

Tan T, Jampol L, Ferris F, Tadayoni R, Sadda S, Chong V Ophthalmol Sci. 2024; 4(3):100449.

PMID: 38313399 PMC: 10837643. DOI: 10.1016/j.xops.2023.100449.